Sivaraman Dandapani

Sivaraman Dandapani has been working in the field of chemistry for over 15 years. From 2019 to present, they have been the Director of Chemistry at Skyhawk Therapeutics. From 2016 to 2019, they were a Scientist - II / Senior Scientist in Medicinal Chemistry at Biogen. From 2007 to 2016, they were a Group Leader / Senior Group Leader in Medicinal Chemistry at the Broad Institute, where they delivered 28 small molecule probes from more than 70 High Throughput Screens and had experience in successful collaborative research for target identification of small molecules. From 2004 to 2007, they were a Post-doctoral researcher at both Boston University and Fluorous Technologies Inc.

Sivaraman Dandapani completed their Ph.D in Chemistry from the University of Pittsburgh between 1998 and 2003. Prior to that, they obtained their M.Sc in Chemistry from the Indian Institute of Technology between 1996 and 1998.